Pnc Financial Services Group, Inc. Phathom Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 273 shares of PHAT stock, worth $1,700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
273
Previous 273
-0.0%
Holding current value
$1,700
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PHAT
# of Institutions
157Shares Held
68.4MCall Options Held
52.3KPut Options Held
635K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$63 Million4.92% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$46.5 Million13.31% of portfolio
-
Jennison Associates LLC7.06MShares$44 Million0.04% of portfolio
-
Invesco Ltd. Atlanta, GA3.67MShares$22.9 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$21.8 Million28.4% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $244M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...